BF.B
33
-4
RL
80
2
DHI
52
-4
KHC
20
2
CVS
52
-6
BLK
61
-2
AMGN
31
-16
WHR
65
-7
HSIC
60
-2
GME
70
2
VTR
55
8
CTSH
60
3
UPS
61
-3
NAVI
52
-3
RSG
76
2
MHK
50
-5
SWKS
51
-2
DAL
79
-4
SNA
65
-3
EQIX
75
-2
BF.B
33
-4
RL
80
2
DHI
52
-4
KHC
20
2
CVS
52
-6
BLK
61
-2
AMGN
31
-16
WHR
65
-7
HSIC
60
-2
GME
70
2
VTR
55
8
CTSH
60
3
UPS
61
-3
NAVI
52
-3
RSG
76
2
MHK
50
-5
SWKS
51
-2
DAL
79
-4
SNA
65
-3
EQIX
75
-2
Financhill
Back

Chicago Atlantic Real Estate Finance Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
15

REFI
Chicago Atlantic Real Estate Finance

Last Price:
16.17
Seasonality Move:
1.74%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.49
Seasonality Move:
14.88%
Sell
15
Chicago Atlantic Real Estate Finance (REFI) is a Sell

Is Chicago Atlantic Real Estate Finance a Buy, Sell or Hold?

  • The current Chicago Atlantic Real Estate Finance [REFI] share price is $16.04. The Score for REFI is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • REFI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REFI Stock Price Chart

What is Chicago Atlantic Real Estate Finance's stock price today?

  • The Chicago Atlantic Real Estate Finance share price today is $16.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REFI is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

REFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 64.63 Buy
Chaikin Money Flow: -32354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.26 - 15.9) Buy
Bollinger Bands (100): (15.34 - 15.96) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

REFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.93 Buy
20-day SMA: 15.64 Buy
50-day SMA: 15.61 Buy
200-day SMA: 15.71 Buy
8-day EMA: 15.93 Buy
20-day EMA: 15.75 Buy
50-day EMA: 15.65 Buy
200-day EMA: 15.62 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Chicago Atlantic Real Estate Finance Earnings Growth & REFI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Chicago Atlantic Real Estate Finance Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):